Use of Prophylactic Anti-Epileptic Drugs-Video

Video Transcription

Video Summary

In this video presentation, Dr. Aditya Pandey from the University of Michigan discusses the use of prophylactic anti-epileptic medication in neurosurgery. He begins by stating his credentials and affiliations, as well as any disclosures related to the topic. Dr. Pandey explains that seizures are common among adults and can have a significant impact on quality of life and finances. He then discusses the two most commonly used anti-epileptic medications, Dilantin and Keppra, explaining their mechanisms of action and dosing. Dr. Pandey presents evidence for the use of anti-epileptic medication in several disease processes, including traumatic brain injury, cerebral subarachnoid hemorrhage, intracerebral hemorrhage, and brain tumors. He highlights studies that support the use of prophylactic anti-epileptic medication in the acute phase of these conditions. However, he also emphasizes that long-term use of anti-epileptic medication is not recommended in these patient populations. Dr. Pandey concludes by discussing ongoing research in the field and providing recommendations for clinical practice. No credits were mentioned in the transcript.

Keywords

prophylactic anti-epileptic medication

neurosurgery

seizures

Dilantin

Keppra